Search

Your search keyword '"Porro, Benedetta"' showing total 207 results

Search Constraints

Start Over You searched for: Author "Porro, Benedetta" Remove constraint Author: "Porro, Benedetta"
207 results on '"Porro, Benedetta"'

Search Results

3. Cardiac arrhythmia catheter ablation procedures guided by x-ray imaging: N-acetylcysteine protection against radiation-induced cellular damage (CARAPACE study): study design

5. Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients

8. Hemostatic System in Takotsubo Patients at Long-Term Follow-Up: A Hidden Activation?

9. Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen

10. Enduring Reactive Oxygen Species Emission Causes Aberrant Protein S-Glutathionylation Transitioning Human Aortic Valve Cells from a Sclerotic to a Stenotic Phenotype

11. Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation

12. Retracted: Poster No. 005 Platelet Thromboxane Inhibition by Low-Dose Aspirin in Polycythemia Vera:Ex Vivo and In Vivo Measurements and In Silico Simulation

13. N-Acetylcysteine Regenerates In Vivo Mercaptoalbumin

16. GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy

25. Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach

26. Oxidized LDL‐dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy

29. Lipidomics analysis of monocytes from patients with acute myocardial infarction reveals lactosylceramide as a new player in monocyte migration

30. Netrin-1 in Atherosclerosis: Relationship between Human Macrophage Intracellular Levels and In Vivo Plaque Morphology

31. A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

32. Red Blood Cell Morphodynamics: A New Potential Marker in High-Risk Patients

33. Plasma phospholipid dysregulation in patients with cystathionine-β synthase deficiency

34. Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.

35. Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy

36. Cardiac arrhythmia catheter ablation procedures guided by x-ray imaging: N-acetylcysteine protection against radiation-induced cellular damage (CARAPACE study): study design

37. Relationship Between Plasma Osteopontin and Arginine Pathway Metabolites in Patients With Overt Coronary Artery Disease

38. A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

39. Untargeted Metabolomics to Go beyond the Canonical Effect of Acetylsalicylic Acid

41. Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

42. Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies

43. Endothelial Dysfunction in Patients with Severe Mitral Regurgitation

44. 12(S)-Hydroxyeicosatetraenoic acid downregulates monocyte-derived macrophage efferocytosis: New insights in atherosclerosis

47. Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

49. Does Fluoroscopy Induce DNA Oxidative Damage in Patients Undergoing Catheter Ablation?

Catalog

Books, media, physical & digital resources